TRIM29 and thyroid gland carcinoma: In thyroid carcinoma, high expression of TRIM29 activates PI3K/AKT signaling, which circumvents cell cycle arrest at the G0/G1 phase and enhances cancer cell resistance to chemotherapy (87).